R. Steffensen

744 total citations
15 papers, 576 citations indexed

About

R. Steffensen is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, R. Steffensen has authored 15 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 5 papers in Genetics and 4 papers in Hematology. Recurrent topics in R. Steffensen's work include Complement system in diseases (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Platelet Disorders and Treatments (3 papers). R. Steffensen is often cited by papers focused on Complement system in diseases (13 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers) and Platelet Disorders and Treatments (3 papers). R. Steffensen collaborates with scholars based in Denmark, Brazil and Germany. R. Steffensen's co-authors include Steffen Thiel, Jens C. Jensenius, Lisbeth Jensen, Steen V. Petersen, Kim Varming, Iara Messias-Reason, Troels Krarup Hansen, Kerstin Hoffmann, Jens Christian Jensenius and Charlotte Mehlin Sørensen and has published in prestigious journals such as Frontiers in Immunology, Human Reproduction and Journal of Immunological Methods.

In The Last Decade

R. Steffensen

15 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Steffensen Denmark 12 463 129 81 58 58 15 576
Lone Schejbel Denmark 13 454 1.0× 165 1.3× 99 1.2× 64 1.1× 58 1.0× 43 604
Róbert Szász Hungary 9 313 0.7× 254 2.0× 80 1.0× 104 1.8× 86 1.5× 28 640
Maiken L. Henriksen Denmark 9 282 0.6× 87 0.7× 40 0.5× 95 1.6× 42 0.7× 16 412
A.G. Sjöholm Sweden 17 489 1.1× 191 1.5× 129 1.6× 66 1.1× 89 1.5× 29 700
Mina Akaiwa Japan 9 458 1.0× 48 0.4× 72 0.9× 86 1.5× 77 1.3× 9 659
Roseanna Hargreaves United Kingdom 14 550 1.2× 232 1.8× 42 0.5× 95 1.6× 61 1.1× 22 856
J. Simón Mexico 14 248 0.5× 116 0.9× 51 0.6× 36 0.6× 86 1.5× 23 667
Fariba Vaziri‐Sani Sweden 17 389 0.8× 184 1.4× 46 0.6× 67 1.2× 49 0.8× 34 922
Nesrin Gülez Türkiye 15 388 0.8× 83 0.6× 90 1.1× 165 2.8× 34 0.6× 55 569
Gurpanna Saggu United States 10 319 0.7× 107 0.8× 49 0.6× 71 1.2× 23 0.4× 13 419

Countries citing papers authored by R. Steffensen

Since Specialization
Citations

This map shows the geographic impact of R. Steffensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Steffensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Steffensen more than expected).

Fields of papers citing papers by R. Steffensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Steffensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Steffensen. The network helps show where R. Steffensen may publish in the future.

Co-authorship network of co-authors of R. Steffensen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Steffensen. A scholar is included among the top collaborators of R. Steffensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Steffensen. R. Steffensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Laugesen, Esben, Jakob Appel Østergaard, Kristian Løkke Funck, et al.. (2022). High MBL-expressing genotypes are associated with deterioration in renal function in type 2 diabetes. Frontiers in Immunology. 13. 1080388–1080388. 4 indexed citations
2.
Steffensen, R., Kristian Løkke Funck, Esben Laugesen, et al.. (2017). Plasma levels of MASP-1, MASP-3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene. Clinical & Experimental Immunology. 189(1). 103–112. 17 indexed citations
3.
Boldt, Angelica Beate Winter, R. Steffensen, Steffen Thiel, et al.. (2011). Multiplex sequence-specific polymerase chain reaction reveals new MASP2 haplotypes associated with MASP-2 and MAp19 serum levels. Human Immunology. 72(9). 753–760. 20 indexed citations
4.
Ytting, Henriette, I. J. Christensen, R. Steffensen, et al.. (2010). Mannan‐Binding Lectin (MBL) and MBL‐Associated Serine Protease 2 (MASP‐2) Genotypes in Colorectal Cancer. Scandinavian Journal of Immunology. 73(2). 122–127. 24 indexed citations
5.
Matthijsen, Robert A., Joep P. M. Derikx, R. Steffensen, et al.. (2009). Mannose-binding lectin null alleles are associated with preserved epithelial cell integrity following intestinal ischemia reperfusion in man. Molecular Immunology. 46(11-12). 2244–2248. 9 indexed citations
6.
Christiansen, Ole Bjarne, Henriette Svarre Nielsen, Marie Lund, R. Steffensen, & Kim Varming. (2008). Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses. Human Reproduction. 24(2). 291–299. 32 indexed citations
7.
Boldt, Angelica Beate Winter, Lilian Pereira‐Ferrari, R. Steffensen, et al.. (2008). Mannan-binding lectinMBL2gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy. Clinical & Experimental Immunology. 152(2). 258–264. 41 indexed citations
8.
Thiel, Steffen, R. Steffensen, Ib Jarle Christensen, et al.. (2007). Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes and Immunity. 8(2). 154–163. 72 indexed citations
9.
Olesen, Hanne Vebert, Jens C. Jensenius, R. Steffensen, Steffen Thiel, & Peter Oluf Schiøtz. (2006). The mannan-binding lectin pathway and lung disease in cystic fibrosis—dysfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clinical Immunology. 121(3). 324–331. 44 indexed citations
10.
Mølle, Ingolf, Niels Anker Peterslund, Steffen Thiel, & R. Steffensen. (2006). MBL2 polymorphism and risk of severe infections in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplantation. 38(8). 555–560. 23 indexed citations
11.
Sørensen, Charlotte Mehlin, Troels Krarup Hansen, R. Steffensen, Jens C. Jensenius, & Steffen Thiel. (2006). Hormonal regulation of mannan-binding lectin synthesis in hepatocytes. Clinical & Experimental Immunology. 145(1). 173–182. 53 indexed citations
12.
Thiel, Steffen, et al.. (2004). Mannan‐Binding Lectin and RSV Lower Respiratory Tract Infection Leading to Hospitalization in Children: A Case–Control Study from Soweto, South Africa. Scandinavian Journal of Immunology. 60(1-2). 184–188. 14 indexed citations
13.
Hansen, Troels Krarup, Lise Tarnow, Steffen Thiel, et al.. (2004). Association between Mannose‐Binding Lectin and Vascular Complications in Type 1 Diabetes. Scandinavian Journal of Immunology. 59(6). 613–613. 10 indexed citations
14.
Steffensen, R., Kerstin Hoffmann, & Kim Varming. (2003). Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. Journal of Immunological Methods. 278(1-2). 191–199. 43 indexed citations
15.
Petersen, Steen V., Steffen Thiel, Lisbeth Jensen, R. Steffensen, & Jens C. Jensenius. (2001). An assay for the mannan-binding lectin pathway of complement activation. Journal of Immunological Methods. 257(1-2). 107–116. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026